células madre desarrolladas recientemente para tratar la enfermedad de Parkinson

Cell replacement plays an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD). In the Journal of Parkinson’s Disease, experts describe how newly developed stem cell technologies could be used to treat PD and discuss the challenges, as well as the great promise, of stem cell treatment.

Stem cells can differentiate into any type of tissue found in the body, and as a result, can provide nearly limitless potential for medical applications. Current studies are researching how stem cells may be used to prevent or cure diseases and injuries such as Parkinson’s disease, type 1 diabetes, heart disease, spinal cord injury, Alzheimer’s disease, stroke, burns, osteoarthritis and many other types of injury and chronic disease.

Traditional Treatment for Parkinson´s disease is based on dopamine-modulating therapies. These therapies increase dopamine levels and improve motor impairment associated with the disease. However, these treatments have significant long-term limitations and side effects. Unlike traditional treatments, stem cell technology shows promise for treating the underlying cause of the disease.

There is still no cure for Parkinson’s; traditional medicine only can only partially improve problems with movement and coordination. Using stem cells as a source of transplantable dopamine-producing nerve cells will revolutionize care for patients diagnosed with PD. A single application could potentially reduce or eliminate the need for dopamine-based medications.

Stem cell science is progressing rapidly and researchers are working hard to quickly develop and enroll patients into clinical trials. The recent advances in stem cell technology has shown it is possible to safely and consistently grow unlimited amounts of dopamine-producing nerve cells in the laboratory for transplantation.

Regenerative Medicine is moving quickly and the results are very exciting. The National Institutes of Health (NIH) estimates that doctors diagnose approximately 50,000 new cases of Parkinson’s disease each year. As the second leading cause of neurodegenerative disease in is important to accelerate the rate of research in this area.

Stem cell transplantation, at the sites of neuronal degeneration, is a promising approach for the treatment of different neurological diseases such as Parkinson´s disease. Researcher have shown human neural stem cells transplanted into brains can differentiate into neural cells and significantly improve cognitive function.

The Stem Cells Transplant Institute

Stem cell therapy, at the Stem Cells Transplant Institute in Costa Rica, can help improve the signs and symptoms of Parkinson´s disease, such us:

  • Tremor. A tremor, or shaking, usually begins in a limb, often your hand or fingers
  • Slowed movement
  • Rigid muscles
  • Impaired posture and balance
  • Loss of automatic movements
  • Changes in speech
  • Changes in writing

In the United States, the FDA has approved stem cell-based products to treat only certain blood disorders. For patients with Parkinson’s disease this means they are limited to treatment through clinical trials. The Stem Cells Transplant Institute, in Costa Rica, provides high quality stem cell therapy. All of our experts are US certified by the American Academy of Regenerative and Anti-Aging Medicine.

Mesenchymal stem cells have been shown to repair and regenerate neurons in the brain, reduce levels of free radicals, improve synaptic connection from damaged neurons and regulate inflammation.

Journal Reference:

  1. Claire Henchcliffe, Malin Parmar. Repairing the Brain: Cell Replacement Using Stem Cell-Based TechnologiesJournal of Parkinson’s Disease, 2018; 8 (s1): S131 DOI: 10.3233/JPD-181488
Share